Navigation Links
Ruedi Waeger Receives the 2010 Robert W. Reilly Leadership Award from Plasma Protein Therapeutics Association

RESEARCH TRIANGLE PARK, N.C., June 25 /PRNewswire-FirstCall/ -- Ruedi Waeger, Ph.D., former president and CEO of Aventis Behring LLC and a member of the Talecris Board of Directors, was honored with the Robert W. Reilly Leadership award June 15 at the 2010 Plasma Protein Forum in Reston, VA.

The award is sponsored by the Plasma Protein Therapeutics Association (PPTA) and recognizes individuals who exemplify the leadership qualities of Robert Reilly, former leader of the PPTA. Reilly's efforts improved the quality of plasma products in the U.S. and enhanced the reputation of the plasma therapeutics industry worldwide.

Waeger was bestowed the award because of his significant contributions toward improving patient access to therapies, ensuring the highest quality and safety of plasma-derived products, and striving to achieve worldwide regulatory standardization of protein therapies.

"Ruedi's accomplishments throughout his 30-year career have contributed immensely to the field of protein therapeutics, and we are pleased that his accomplishments have been recognized by the industry," said Lawrence D. Stern, chairman and CEO of Talecris. "Ruedi's breadth of knowledge and experience continue to be tremendously valuable to Talecris, and we congratulate him on having received this honor from the PPTA."

Waeger has served on the Talecris Board since April 2005 and currently chairs the compliance committee. He also serves on the nominating and governance committees.  Waeger has more than 30 years of experience in the global pharmaceutical and therapeutic protein industries. Prior to joining the Talecris board, Waeger served as President and CEO of the plasma therapeutics company Aventis Behering LLC. Prior to that, he served as President and CEO of ZLB Central Laboratories and the Blood Transfusion Service of the Swiss Red Cross. Waeger earned a Ph.D. in biochemistry from the Swiss Federal Institute of Technology.

About the Robert W. Reilly Leadership Award

Robert Reilly was a leader in the plasma therapeutics industry association from 1992 to 1998. He created the first educational programs and industry symposia to confront the challenges facing the plasma industry worldwide. He also contributed significantly to the development of voluntary industry standards for quality plasma programs throughout the U.S., and his work helped open communications and build relationships with regulatory authorities and consumer groups.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit:

SOURCE Talecris Biotherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Shire Receives CHMP Positive Opinion for VPRIV(TM) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease in the European Union
2. Corgenix Receives Additional European Patent, Announces Publication of Important Clinical Study on AtherOx(R) Technology
3. Aeterna Zentaris Receives US$12 Million on Closing of Registered Direct Offering
4. Nile Therapeutics Receives Notice Related to Nasdaq Minimum Closing Bid Price Rule
5. Alexandria Real Estate Equities, Inc. Receives Final Approval From City of Cambridge to Develop Its East Cambridge State-of-the-Art Life Science Community
6. Oncolytics Biotech(R) Inc. Receives Approval from Belgium FAMHP to Conduct Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers
7. Fenwal Scientist Receives Research Award for Work on Photopheresis Therapy
8. China Sky One Medical Receives GMP Re-Certification
9. SyntheMed Receives CE Mark Approval for REPEL-GYN™
10. Repligen Receives Orphan Drug Designation from the FDA for RG2833 for Friedreichs Ataxia
11. Biomedical Structures Receives Growth Capital from Ampersand Ventures to Fund Ongoing Expansion
Post Your Comments:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), ... free webinar on Performing Quality Investigations: Getting to Root Cause. ... no charge. , Incomplete investigations are still a major concern to the Regulatory ...
Breaking Biology Technology:
(Date:5/12/2016)... 12, 2016 , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: ) , ... services, but it also plays a fundamental part in enabling ...
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
Breaking Biology News(10 mins):